APL is a distinguished subtype of AML characterized by a specific genetic alteration of t(15;17)(q22;q21), PML-RARα fusion, and proliferation of promyelocytes in peripheral blood and bone marrow [4]. The gene discussed is PML; the disease is acute myeloid leukemia.